​

CAMP4 Therapeutics (CAMP) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

CAMP Stock Forecast

CAMP4 Therapeutics (CAMP) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $17.50, with a high of $18.00 and a low of $17.00. This represents a 252.11% increase from the last price of $4.97.

- $4 $8 $12 $16 $20 High: $18 Avg: $17.5 Low: $17 Last Closed Price: $4.97

CAMP Stock Rating

CAMP4 Therapeutics stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (71.43%), 1 Hold (14.29%), 1 Sell (14.29%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 1 5 Strong Sell Sell Hold Buy Strong Buy

CAMP Forecast vs Benchmarks

TypeNameUpside
StockCAMP4 Therapeutics252.11%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts-22
Avg Price Target-$17.50$17.50
Last Closing Price$4.97$4.97$4.97
Upside/Downside-252.11%252.11%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2522---4
Dec, 2422---4
Nov, 242341-10
Oct, 24--2--2
Sep, 24144--9
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 05, 2024Mani ForooharLeerink Partners$17.00$9.6077.08%242.05%
Nov 05, 2024Edward TenthoffPiper Sandler$18.00$9.6087.50%262.17%
Aug 16, 2022Anthony StossCraig-Hallum$10.00$5.8072.41%101.21%
Jun 24, 2022Jerry RevichGoldman Sachs$5.00$4.931.42%0.60%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Nov 05, 2024William BlairOutperforminitialise
Nov 05, 2024Leerink PartnersOutperforminitialise
Nov 05, 2024Piper SandlerOverweightinitialise
Jun 26, 2023Raymond JamesBuyupgrade
Oct 14, 2022Goldman SachsSellSellhold
Jun 24, 2022Goldman SachsSellSellhold

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 $1 $2 $3 Nov 20 Nov 21 Nov 22 Nov 23 Nov 24 Nov 25 Nov 26 Nov 27
Nov 20Nov 21Nov 22Nov 23Nov 24Nov 25Nov 26Nov 27
Reported---$-2.52----
Avg Forecast$2.86$0.77$-2.39$-5.27$-2.10$0.95$-2.42-
High Forecast$2.81$0.75$-2.39$-5.27$-3.23$0.86$-2.46-
Low Forecast$2.90$0.78$-2.39$-5.27$-1.29$1.01$-2.38-
Surprise %----52.18%----

Revenue Forecast

$150M $190M $230M $270M $310M $350M Nov 20 Nov 21 Nov 22 Nov 23 Nov 24 Nov 25 Nov 26 Nov 27
Nov 20Nov 21Nov 22Nov 23Nov 24Nov 25Nov 26Nov 27
Reported---$186.23M----
Avg Forecast$335.33M$295.88M$295.08M$237.48M$229.10M$252.01M$291.96M$152.47M
High Forecast$330.91M$291.97M$295.08M$237.48M$216.83M$239.28M$291.96M$152.47M
Low Forecast$338.65M$298.80M$295.08M$237.48M$241.38M$264.74M$291.96M$152.47M
Surprise %----21.58%----

Net Income Forecast

$-150M $-90M $-30M $30M $90M $150M Nov 20 Nov 21 Nov 22 Nov 23 Nov 24 Nov 25 Nov 26 Nov 27
Nov 20Nov 21Nov 22Nov 23Nov 24Nov 25Nov 26Nov 27
Reported---$-93.26M----
Avg Forecast$105.83M$-55.33M$-88.56M$-101.35M$-77.75M$34.69M$-89.58M-
High Forecast$104.02M$-66.39M$-88.56M$-121.62M$-119.61M$32.01M$-91.04M-
Low Forecast$107.19M$-44.26M$-88.56M$-81.08M$-47.71M$37.36M$-88.11M-
Surprise %----7.98%----

CAMP Forecast FAQ

Is CAMP4 Therapeutics stock a buy?

CAMP4 Therapeutics stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that CAMP4 Therapeutics is a favorable investment for most analysts.

What is CAMP4 Therapeutics's price target?

CAMP4 Therapeutics's price target, set by 7 Wall Street analysts, averages $17.5 over the next 12 months. The price target range spans from $17 at the low end to $18 at the high end, suggesting a potential 252.11% change from the previous close price of $4.97.

How does CAMP4 Therapeutics stock forecast compare to the average forecast of its sector, industry, and investment themes?

CAMP4 Therapeutics stock forecast shows a 252.11% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for CAMP4 Therapeutics over the past three months?

  • January 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 20.00% Strong Buy, 30.00% Buy, 40.00% Hold, 10.00% Sell, 0% Strong Sell.

What is CAMP4 Therapeutics’s EPS forecast?

CAMP4 Therapeutics's average annual EPS forecast for its fiscal year ending in November is -2.1 for 2024, a -16.67% decrease from the reported $-2.52 in 2023. The prediction for 2025 is $0.95, $-2.42 for 2026, and $0 for 2027.

What is CAMP4 Therapeutics’s revenue forecast?

CAMP4 Therapeutics's average annual revenue forecast for its fiscal year ending in November is $229.1M for 2024, a 23.02% increase from the reported $186.23M in 2023. The forecast for 2025 is $252.01M, $291.96M for 2026, and $152.47M for 2027.

What is CAMP4 Therapeutics’s net income forecast?

For its fiscal year ending in November, CAMP4 Therapeutics's average annual net income forecast is $-77.748M for 2024, reflecting a -16.63% decrease from the reported $-93.261M in 2023. The projection for 2025 is $34.69M, $-89.576M for 2026, and $0 for 2027.